Niagen Bioscience, Inc. (NAGE)
4.38
-0.14
(-3.10%)
USD |
NASDAQ |
Apr 02, 16:00
4.385
0.00 (0.00%)
After-Hours: 20:00
Niagen Bioscience EPS Diluted (Quarterly) : 0.0489 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SIGA Technologies, Inc. | -0.0758 |
| Nephros, Inc. | 0.0055 |
| Corcept Therapeutics, Inc. | 0.1994 |
| Verastem, Inc. | -0.3947 |
| Anavex Life Sciences Corp. | -0.0638 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.132M |
| Revenue (Quarterly) | 33.84M |
| Total Expenses (Quarterly) | 29.71M |
| Enterprise Value | 288.78M |
| Gross Profit Margin (Quarterly) | 64.14% |
| Profit Margin (Quarterly) | 12.21% |
| Earnings Yield | 4.66% |
| Operating Earnings Yield | 3.83% |
| Normalized Earnings Yield | 4.669 |